Logo Image
|Articles|February 22, 2021

Hospitalizations Plummet in Scotland After Vaccinations

Author(s)Killian Meara

Mediterranean region imposes partial lockdown following a surge in cases.

On Monday, investigators stated that Scotland’s coronavirus disease 2019 (COVID-19) vaccination program has led to a steep reduction in hospitalizations, according to data from the University of Edinburgh, the University of Strathclyde and Public Health Scotland. It was discovered that the Oxford-AstraZeneca and the Pfizer-BioNTech vaccines reduced hospital admissions by 94% and 85% respectively. This information is encouraging and is proving that the shots work in the real world as they did in controlled studies.

In Southern California, the CAL.20C variant of COVID-19 has been linked with a recent surge in cases in the region. The strain originated from a group of viruses that spread from Europe to New York earlier in the course of the pandemic and was first detected in California in July. On January 22nd, CAL.20C accounted for 44% of new cases in Southern California and is distinct from other mutations like the UK and South African variants.

Additionally, a new report from the US Centers for Disease Control and Prevention (CDC) has shown that the COVID-19 vaccines have relatively low rates of adverse reactions. Between December 14th and January 13th, there was more than 13.7 million vaccine doses administered with 6,994 reports of adverse events. Of those, 6,354 were deemed non-serious and 640 were classified as serious.

United States
63.09 million
18.86 per 100
China
40.52 million
2.82 per 100
United Kingdom
18.2 million
26.81 per 100
India
11.09 million
0.8 per 100
Israel
7.36 million
85.01 per 100
Brazil
6.95 million
3.27 per 100
Turkey
6.57 million
7.79 per 100
United Arab Emirates
5.55 million
56.16 per 100
Germany
5.07 million
6.05 per 100
Russia
3.9 million
2.67 per 100

Data Table per Our World in Data (Feb 21, 2021, 12 AM EST)

West Virginia, after a bumpy start in their program, now has one of the highest vaccination rates in the world. The state has administered almost 450,000 doses, with more than 9% of its population receiving both shots.

California
7,453,468
18.98 per 100
Texas
4,673,868
15.91 per 100
Florida
4,387,051
20.18 per 100
New York
3,621,973
18.73 per 100
Illinois
2,339,546
18.46 per 100
Pennsylvania
2,306,828
18.01 per 100
Ohio
2,140,688
18.31 per 100
North Carolina
2,068,505
19.72 per 100
Michigan
1,933,648
19.56 per 100
Georgia
1,850,856
17.43 per 100

Data Table per CDC COVID-19 Tracker (Feb 21, 2021, 6 AM EST)

For more information on COVID-19 vaccination research, distribution, and assessment, check out some of these recent Contagion stories:

Pfizer Could More Than Double Its Weekly COVID-19 Vaccine Production in March

Pfizer, BioNTech Seek FDA Approval Easing Vaccine Temperature Requirements

Higher Efficacy Found With Longer Interval Between Doses of Oxford COVID-19 Vaccine

Related to this article

View more
FAQ: What You Need to Know About West Nile Virus in 2026
FAQ: What You Need to Know About West Nile Virus in 2026
After 2 adults died of West Nile virus in central North Carolina this month, this FAQ explains how the mosquito-borne virus spreads, who faces the greatest risk of severe neuroinvasive disease, and how clinicians can diagnose, manage, and help prevent infection when no vaccine or antiviral treatment exists.
Read more
NFID Survey Finds Respiratory Vaccine Gap Driven by Lack of Clarity, Not Hesitancy
NFID Survey Finds Respiratory Vaccine Gap Driven by Lack of Clarity, Not Hesitancy
The National Foundation for Infectious Diseases (NFID) recently held its respiratory season kick-off, which included the release of its annual respiratory disease survey. This year, the survey revealed the gap between vaccine support and uptake. Robert Hopkins Jr, MD, medical director of NFID delves deeper into the findings of the survey and the vaccine uptake challenges associated with certain immunizations.
Read more